When immune cells strike, precision is everything. New research reveals how natural killer and T cells orchestrate the ...

Dr. Simsek began by emphasizing that their group had previously shown that CD8+ T cells expressing PD-1 but lacking TIM-3 or LAG-3 are associated with improved clinical outcomes to anti–PD-1 ...

Democracy depends not just on officeholders, but on the quiet vigilance of institutional and civic actors—the novel “fourth ...

Johnson & Johnson today announced promising new results from the Phase 1b/2 OrigAMI-4 study evaluating the efficacy and safety of subcutaneous (SC) amivantamab monotherapy in patients with human ...